APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Prothrombin Complex

Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.

Selected research

Market Structure

Global Human Prothrombin Complex Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025187 pages

Choose your research edition.

Industry ResearchHuman Prothrombin Complex Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Prothrombin Complex Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Human Prothrombin Complex Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Prothrombin Complex Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Prothrombin Complex Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.

Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.

North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.

Read the full market overview

In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.

This report provides an overview of the global Human Prothrombin Complex market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Human Prothrombin Complex and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human Prothrombin Complex sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Human Prothrombin Complex market size, projected growth trends, production technologies, key applications, and end-use industries.

Human Prothrombin Complex Segment by Company

Takeda

CSL

Grifols

Octapharma

Hualan Biological

Meheco Xinxing Pharma

Human Prothrombin Complex Segment by Type

500 IU/Vial

600 IU/Vial

1000 IU/Vial

Others

Human Prothrombin Complex Segment by Application

Hemophilia B

Vitamin K Deficiency

Others

Human Prothrombin Complex Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Prothrombin Complex market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Prothrombin Complex and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Prothrombin Complex.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Human Prothrombin Complex market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Prothrombin Complex manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Human Prothrombin Complex in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Human Prothrombin Complex in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Human Prothrombin Complex Industry Trends Table 2. Human Prothrombin Complex Industry Drivers Table 3. Human Prothrombin Complex Industry Opportunities and Challenges Table 4. Human Prothrombin Complex Industry Restraints Table 5. Global Human Prothrombin Complex Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Human Prothrombin Complex Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Human Prothrombin Complex Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Human Prothrombin Complex Sales Market Share by Manufacturers Table 9. Global Human Prothrombin Complex Average Sales Price (M USD/Unit) of Manufacturers (2021-2026) Table 10. Global Human Prothrombin Complex Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Human Prothrombin Complex Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Human Prothrombin Complex Manufacturers, Product Type & Application Table 13. Global Human Prothrombin Complex Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Human Prothrombin Complex by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 500 IU/Vial Table 17. Major Manufacturers of 600 IU/Vial Table 18. Major Manufacturers of 1000 IU/Vial Table 19. Major Manufacturers of Others Table 20. Global Human Prothrombin Complex Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Human Prothrombin Complex Sales by Type (2021-2026) & (K Units) Table 22. Global Human Prothrombin Complex Sales by Type (2027-2032) & (K Units) Table 23. Global Human Prothrombin Complex Sales Market Share by Type (2021-2026) Table 24. Global Human Prothrombin Complex Sales Market Share by Type (2027-2032) Table 25. Global Human Prothrombin Complex Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Human Prothrombin Complex Revenue by Type (2021-2026) & (K Units) Table 27. Global Human Prothrombin Complex Revenue by Type (2027-2032) & (K Units) Table 28. Global Human Prothrombin Complex Revenue Market Share by Type (2021-2026) Table 29. Global Human Prothrombin Complex Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hemophilia B Table 31. Major Manufacturers of Vitamin K Deficiency Table 32. Major Manufacturers of Others Table 33. Global Human Prothrombin Complex Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Human Prothrombin Complex Sales by Application (2021-2026) & (K Units) Table 35. Global Human Prothrombin Complex Sales by Application (2027-2032) & (K Units) Table 36. Global Human Prothrombin Complex Sales Market Share by Application (2021-2026) Table 37. Global Human Prothrombin Complex Sales Market Share by Application (2027-2032) Table 38. Global Human Prothrombin Complex Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Human Prothrombin Complex Revenue by Application (2021-2026) & (K Units) Table 40. Global Human Prothrombin Complex Revenue by Application (2027-2032) & (K Units) Table 41. Global Human Prothrombin Complex Revenue Market Share by Application (2021-2026) Table 42. Global Human Prothrombin Complex Revenue Market Share by Application (2027-2032) Table 43. Global Human Prothrombin Complex Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Human Prothrombin Complex Sales by Region (2021-2026) & (K Units) Table 45. Global Human Prothrombin Complex Sales Market Share by Region (2021-2026) Table 46. Global Human Prothrombin Complex Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Human Prothrombin Complex Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Human Prothrombin Complex Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Human Prothrombin Complex Sales by Country (2021-2026) & (K Units) Table 50. North America Human Prothrombin Complex Sales by Country (2027-2032) & (K Units) Table 51. Europe Human Prothrombin Complex Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Human Prothrombin Complex Sales by Country (2021-2026) & (K Units) Table 53. Europe Human Prothrombin Complex Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Human Prothrombin Complex Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Human Prothrombin Complex Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Human Prothrombin Complex Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Human Prothrombin Complex Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Human Prothrombin Complex Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Human Prothrombin Complex Sales by Country (2027-2032) & (K Units) Table 60. Global Human Prothrombin Complex Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Human Prothrombin Complex Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Human Prothrombin Complex Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Human Prothrombin Complex Revenue Market Share by Region (2021-2026) Table 64. Global Human Prothrombin Complex Revenue Market Share by Region (2027-2032) Table 65. Takeda Company Information Table 66. Takeda Business Overview Table 67. Takeda Human Prothrombin Complex Sales (K Units), Price (M USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Takeda Human Prothrombin Complex Product Portfolio Table 69. Takeda Recent Development Table 70. CSL Company Information Table 71. CSL Business Overview Table 72. CSL Human Prothrombin Complex Sales (K Units), Price (M USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. CSL Human Prothrombin Complex Product Portfolio Table 74. CSL Recent Development Table 75. Grifols Company Information Table 76. Grifols Business Overview Table 77. Grifols Human Prothrombin Complex Sales (K Units), Price (M USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Grifols Human Prothrombin Complex Product Portfolio Table 79. Grifols Recent Development Table 80. Octapharma Company Information Table 81. Octapharma Business Overview Table 82. Octapharma Human Prothrombin Complex Sales (K Units), Price (M USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Octapharma Human Prothrombin Complex Product Portfolio Table 84. Octapharma Recent Development Table 85. Hualan Biological Company Information Table 86. Hualan Biological Business Overview Table 87. Hualan Biological Human Prothrombin Complex Sales (K Units), Price (M USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Hualan Biological Human Prothrombin Complex Product Portfolio Table 89. Hualan Biological Recent Development Table 90. Meheco Xinxing Pharma Company Information Table 91. Meheco Xinxing Pharma Business Overview Table 92. Meheco Xinxing Pharma Human Prothrombin Complex Sales (K Units), Price (M USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Meheco Xinxing Pharma Human Prothrombin Complex Product Portfolio Table 94. Meheco Xinxing Pharma Recent Development Table 95. Key Raw Materials Table 96. Raw Materials Key Suppliers Table 97. Human Prothrombin Complex Distributors List Table 98. Human Prothrombin Complex Customers List Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Human Prothrombin Complex Product Image Figure 2. Global Human Prothrombin Complex Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Prothrombin Complex Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Prothrombin Complex Sales (2021-2032) & (K Units) Figure 5. Global Human Prothrombin Complex Average Price (M USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Human Prothrombin Complex Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 500 IU/Vial Image Figure 9. 600 IU/Vial Image Figure 10. 1000 IU/Vial Image Figure 11. Others Image Figure 12. Global Human Prothrombin Complex Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Human Prothrombin Complex Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Human Prothrombin Complex Sales Market Share by Type (2021-2032) Figure 15. Global Human Prothrombin Complex Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Human Prothrombin Complex Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Human Prothrombin Complex Revenue Market Share by Type (2021-2032) Figure 18. Hemophilia B Image Figure 19. Vitamin K Deficiency Image Figure 20. Others Image Figure 21. Global Human Prothrombin Complex Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Human Prothrombin Complex Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Human Prothrombin Complex Sales Market Share by Application (2021-2032) Figure 24. Global Human Prothrombin Complex Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Human Prothrombin Complex Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Human Prothrombin Complex Revenue Market Share by Application (2021-2032) Figure 27. North America Human Prothrombin Complex Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Human Prothrombin Complex Sales Market Share by Country (2021-2032) Figure 29. U.S. Human Prothrombin Complex Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Human Prothrombin Complex Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Human Prothrombin Complex Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Human Prothrombin Complex Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Human Prothrombin Complex Sales Market Share by Country (2021-2032) Figure 34. Germany Human Prothrombin Complex Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Human Prothrombin Complex Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Human Prothrombin Complex Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Human Prothrombin Complex Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Human Prothrombin Complex Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Human Prothrombin Complex Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Human Prothrombin Complex Sales Market Share by Country (2021-2032) Figure 41. China Human Prothrombin Complex Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Human Prothrombin Complex Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Human Prothrombin Complex Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Human Prothrombin Complex Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Human Prothrombin Complex Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Human Prothrombin Complex Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Human Prothrombin Complex Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Human Prothrombin Complex Sales Market Share by Country (2021-2032) Figure 49. Brazil Human Prothrombin Complex Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Human Prothrombin Complex Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Human Prothrombin Complex Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Human Prothrombin Complex Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Human Prothrombin Complex Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Human Prothrombin Complex Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Human Prothrombin Complex Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Human Prothrombin Complex Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Human Prothrombin Complex Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Human Prothrombin Complex Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Human Prothrombin Complex Revenue (2021-2032) & (US$ Million) Figure 60. North America Human Prothrombin Complex Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Human Prothrombin Complex Revenue (2021-2032) & (US$ Million) Figure 62. Europe Human Prothrombin Complex Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Human Prothrombin Complex Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Human Prothrombin Complex Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Human Prothrombin Complex Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Human Prothrombin Complex Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Human Prothrombin Complex Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Human Prothrombin Complex Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 500 IU/Vial
  • 600 IU/Vial
  • 1000 IU/Vial
  • Others
Applications
  • Hemophilia B
  • Vitamin K Deficiency
  • Others
Companies covered
  • Takeda
  • CSL
  • Grifols
  • Octapharma
  • Hualan Biological
  • Meheco Xinxing Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Human Prothrombin Complex Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Human Prothrombin Complex Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Human Prothrombin Complex Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Human Prothrombin Complex Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Human Prothrombin Complex Market Dynamics
  1. 2.1 Human Prothrombin Complex Industry Trends
  2. 2.2 Human Prothrombin Complex Industry Drivers
  3. 2.3 Human Prothrombin Complex Industry Opportunities and Challenges
  4. 2.4 Human Prothrombin Complex Industry Restraints
3 Human Prothrombin Complex Market by Manufacturers
  1. 3.1 Global Human Prothrombin Complex Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Human Prothrombin Complex Sales by Manufacturers (2021-2026)
  3. 3.3 Global Human Prothrombin Complex Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Human Prothrombin Complex Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Prothrombin Complex Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Human Prothrombin Complex Manufacturers, Product Type & Application
  7. 3.7 Global Human Prothrombin Complex Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Prothrombin Complex Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Prothrombin Complex Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Prothrombin Complex Tier 1, Tier 2, and Tier 3
4 Human Prothrombin Complex Market by Type
  1. 4.1 Human Prothrombin Complex Type Introduction
  2. 4.1.1 500 IU/Vial
  3. 4.1.2 600 IU/Vial
  4. 4.1.3 1000 IU/Vial
  5. 4.1.4 Others
  6. 4.2 Global Human Prothrombin Complex Sales by Type
  7. 4.2.1 Global Human Prothrombin Complex Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Human Prothrombin Complex Sales by Type (2021-2032)
  9. 4.2.3 Global Human Prothrombin Complex Sales Market Share by Type (2021-2032)
  10. 4.3 Global Human Prothrombin Complex Revenue by Type
  11. 4.3.1 Global Human Prothrombin Complex Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Human Prothrombin Complex Revenue by Type (2021-2032)
  13. 4.3.3 Global Human Prothrombin Complex Revenue Market Share by Type (2021-2032)
5 Human Prothrombin Complex Market by Application
  1. 5.1 Human Prothrombin Complex Application Introduction
  2. 5.1.1 Hemophilia B
  3. 5.1.2 Vitamin K Deficiency
  4. 5.1.3 Others
  5. 5.2 Global Human Prothrombin Complex Sales by Application
  6. 5.2.1 Global Human Prothrombin Complex Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Prothrombin Complex Sales by Application (2021-2032)
  8. 5.2.3 Global Human Prothrombin Complex Sales Market Share by Application (2021-2032)
  9. 5.3 Global Human Prothrombin Complex Revenue by Application
  10. 5.3.1 Global Human Prothrombin Complex Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Human Prothrombin Complex Revenue by Application (2021-2032)
  12. 5.3.3 Global Human Prothrombin Complex Revenue Market Share by Application (2021-2032)
6 Global Human Prothrombin Complex Sales by Region
  1. 6.1 Global Human Prothrombin Complex Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Human Prothrombin Complex Sales by Region (2021-2032)
  3. 6.2.1 Global Human Prothrombin Complex Sales by Region (2021-2026)
  4. 6.2.2 Global Human Prothrombin Complex Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Human Prothrombin Complex Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Human Prothrombin Complex Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Human Prothrombin Complex Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Human Prothrombin Complex Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Human Prothrombin Complex Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Human Prothrombin Complex Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Human Prothrombin Complex Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Human Prothrombin Complex Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Human Prothrombin Complex Revenue by Region
  1. 7.1 Global Human Prothrombin Complex Revenue by Region
  2. 7.1.1 Global Human Prothrombin Complex Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Human Prothrombin Complex Revenue by Region (2021-2026)
  4. 7.1.3 Global Human Prothrombin Complex Revenue by Region (2027-2032)
  5. 7.1.4 Global Human Prothrombin Complex Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Human Prothrombin Complex Revenue (2021-2032)
  8. 7.2.2 North America Human Prothrombin Complex Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Human Prothrombin Complex Revenue (2021-2032)
  11. 7.3.2 Europe Human Prothrombin Complex Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Human Prothrombin Complex Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Human Prothrombin Complex Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Human Prothrombin Complex Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Human Prothrombin Complex Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Human Prothrombin Complex Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 CSL
  8. 8.2.1 CSL Company Information
  9. 8.2.2 CSL Business Overview
  10. 8.2.3 CSL Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CSL Human Prothrombin Complex Product Portfolio
  12. 8.2.5 CSL Recent Developments
  13. 8.3 Grifols
  14. 8.3.1 Grifols Company Information
  15. 8.3.2 Grifols Business Overview
  16. 8.3.3 Grifols Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Grifols Human Prothrombin Complex Product Portfolio
  18. 8.3.5 Grifols Recent Developments
  19. 8.4 Octapharma
  20. 8.4.1 Octapharma Company Information
  21. 8.4.2 Octapharma Business Overview
  22. 8.4.3 Octapharma Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Octapharma Human Prothrombin Complex Product Portfolio
  24. 8.4.5 Octapharma Recent Developments
  25. 8.5 Hualan Biological
  26. 8.5.1 Hualan Biological Company Information
  27. 8.5.2 Hualan Biological Business Overview
  28. 8.5.3 Hualan Biological Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hualan Biological Human Prothrombin Complex Product Portfolio
  30. 8.5.5 Hualan Biological Recent Developments
  31. 8.6 Meheco Xinxing Pharma
  32. 8.6.1 Meheco Xinxing Pharma Company Information
  33. 8.6.2 Meheco Xinxing Pharma Business Overview
  34. 8.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Product Portfolio
  36. 8.6.5 Meheco Xinxing Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Human Prothrombin Complex Value Chain Analysis
  2. 9.1.1 Human Prothrombin Complex Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Human Prothrombin Complex Production Mode & Process
  6. 9.2 Human Prothrombin Complex Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Human Prothrombin Complex Distributors
  9. 9.2.3 Human Prothrombin Complex Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst